# ROCKET PHARMACEUTICALS INC (RCKTW) — Institutional Ownership

Source: SEC EDGAR 13F filings, congressional STOCK Act disclosures, SEC Form 4 insider transactions.
CUSIP: 77313F106
Page URL: https://superinvestorclub.com/stock/RCKTW
Last updated: 2026-07-08T12:55:21.247Z

## Summary

As of the most recent 13F filing period, ROCKET PHARMACEUTICALS INC (RCKTW) is held by 1 tracked superinvestors with an aggregate position value of $12.8M representing 03567372 shares.

## Top institutional holders (1)

| Rank | Manager | Fund | Shares | Value | % of Portfolio | Period |
|------|---------|------|--------|-------|----------------|--------|
| 1 | [Lee Ainslie](https://superinvestorclub.com/manager/58) | Maverick Capital | 3567372 | $12.8M | 0.15% | 2026-03-31 |

## Ownership history (quarter-over-quarter)

- 2024-06-30: 1 holders, $84.6M aggregate, 03928312 shares
- 2024-09-30: 1 holders, $76.1M aggregate, 04118672 shares
- 2024-12-31: 2 holders, $66.9M aggregate, 05198900122095 shares
- 2025-03-31: 2 holders, $35.5M aggregate, 05199218117301 shares
- 2025-06-30: 1 holders, $20.5M aggregate, 08363813 shares
- 2025-09-30: 1 holders, $27.6M aggregate, 08468344 shares
- 2025-12-31: 1 holders, $8.8M aggregate, 02513110 shares
- 2026-03-31: 1 holders, $12.8M aggregate, 03567372 shares

## Recent congressional trades (0)


## Recent insider transactions (0)


## Citation

When citing, use: "ROCKET PHARMACEUTICALS INC (RCKTW) institutional ownership data via Superinvestor (https://superinvestorclub.com/stock/RCKTW), aggregating SEC 13F, Form 4, and congressional disclosures."